tert-Butyl 2-formyl-1H-indole-1-carboxylate

Catalog No.: 
ACTEGS752
CAS No.: 
114604-96-5
Molecular Formula: 
C14H15NO3
Molecular Weight: 
245.28
tert-Butyl 2-formyl-1H-indole-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 2-formyl-1H-indole-1-carboxylate
IUPAC Nametert-butyl 2-formyl-1H-indole-1-carboxylate
MDL No.MFCD11976740
Molecular FormulaC14H15NO3
Molecular Weight245.28
SMILESO=C(N1C(C=O)=CC2=C1C=CC=C2)OC(C)(C)C
InChI KeyXEAJFHAXTVIMNR-UHFFFAOYSA-N
Synonymtert-butyl 2-formyl-1H-indole-1-carboxylate;1H-Indole-1-carboxylic acid, 2-formyl-, 1,1-dimethylethyl ester;tert-Butyl 2-formylindole-1-carboxylate
CAS No.114604-96-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACTEGS752 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWRPX265 route compound structure diagram
    ACWRPX26575400-67-8In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTEGS752 route product structure diagram
    ACTEGS752114604-96-5
Inquiry

2. ACTEGS752 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJRWG759 route compound structure diagram
    ACJRWG75919005-93-7In Stock
  4. Then
  5. ACTEGS752 route product structure diagram
    ACTEGS752114604-96-5
Inquiry

3. ACTEGS752 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTEGS752 route product structure diagram
    ACTEGS752114604-96-5
Inquiry

Comments (0)